Carson Wealth (CWM LLC)’s Aerie Pharmaceuticals AERI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-8
Closed 4394
2022
Q3
$0 Hold
8
﹤0.01% 4308
2022
Q2
$0 Hold
8
﹤0.01% 4213
2022
Q1
$0 Sell
8
-71
-90% -$547 ﹤0.01% 4008
2021
Q4
$1K Buy
+79
New +$827 ﹤0.01% 3449
2021
Q2
$3K Hold
170
﹤0.01% 2594
2021
Q1
$3K Hold
170
﹤0.01% 2592
2020
Q4
$3K Hold
170
﹤0.01% 2591
2020
Q3
$3K Hold
170
﹤0.01% 2590
2020
Q2
$3K Hold
170
﹤0.01% 2588
2020
Q1
$3K Hold
170
﹤0.01% 2586
2019
Q4
$3K Hold
170
﹤0.01% 2585
2019
Q3
$3K Hold
170
﹤0.01% 2585
2019
Q2
$3K Hold
170
﹤0.01% 2585
2019
Q1
$3K Buy
170
+143
+530% +$6.29K ﹤0.01% 2584
2018
Q4
$1K Buy
+27
New +$1.27K ﹤0.01% 2036

Carson Wealth (CWM LLC)'s AERI Position: Q4 2022 in Review

Carson Wealth (CWM LLC) sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 8 shares.

Carson Wealth (CWM LLC) first reported a position in AERI in Q4 2018 and held it in 15 quarters. The position peaked at $3K in Q2 2021. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

  • Carson Wealth (CWM LLC) reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 8 Aerie Pharmaceuticals shares in Q4 2022.
  • Carson Wealth (CWM LLC) first reported a position in Aerie Pharmaceuticals in Q4 2018 and held it in 15 quarters.
  • Carson Wealth (CWM LLC)'s Aerie Pharmaceuticals position peaked at $3K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q4 2022, filed 1 Feb 2023.